Top Markets
Coin of the day
Evaxion Biotech A/S Evaxion Biotech A/S

Evaxion Biotech A/S

EVAX
Classement en actions #29854
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to... Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
Prix de l'action
$2.99
Capitalisation boursière
$18.85M
Changement (1 jour)
-5.24%
Changement (1 an)
-1.81%
Pays
DK
Échange Evaxion Biotech A/S (EVAX)

Catégorie

Historique des divisions d’actions pour Evaxion Biotech A/S (EVAX)
L’action Evaxion Biotech A/S (symbole : EVAX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 19, 2026.
Une action EVAX achetée avant le Aug 19, 2026 équivaudrait aujourd’hui à 0 actions EVAX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH